<SEC-DOCUMENT>0001415889-25-013712-index.html : 20250519
<SEC-HEADER>0001415889-25-013712.hdr.sgml : 20250519
<ACCEPTANCE-DATETIME>20250519184700
ACCESSION NUMBER:		0001415889-25-013712
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250515
FILED AS OF DATE:		20250519
DATE AS OF CHANGE:		20250519

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			FRIEDMAN CATHY
		CENTRAL INDEX KEY:			0001411874
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40502
		FILM NUMBER:		25965589

	MAIL ADDRESS:	
		STREET 1:		C/O INNOVIVA, INC.
		STREET 2:		2000 SIERRA POINT PARKWAY, SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lyell Immunopharma, Inc.
		CENTRAL INDEX KEY:			0001806952
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				833006753
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		201 HASKINS WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650 695-0677

	MAIL ADDRESS:	
		STREET 1:		201 HASKINS WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-05192025_100556.xml
<TEXT>
Document 1 - file: form4-05192025_100556.html

Document 1 - RAW XML: form4-05192025_100556.xml

</DOCUMENT>
</SEC-DOCUMENT>